According to the Union Minister of Health and Family Welfare, India is in continuous touch with Uzbekistan’s national drug authority over claims of Noida-based cough syrups reportedly related to the deaths of 18 children in Uzbekistan.
According to the statement, there have been allegations from Uzbekistan of tainted cough syrup Dok1 Max manufactured by the Indian business Marion Biotech, Noida, Uttar Pradesh.
“Under the guidance of Union Minister of Health and Family Welfare Mansukh Mandaviya, the Central Drugs Standard Control Organization (CDSCO) has been in constant touch with Uzbekistan’s national drug authority about the problem since December 27, 2022,” the statement said.
UP Drug Control and the CDSCO team conducted a combined examination of the manufacturer’s NOIDA facility, Marion Biotech, as soon as they received the information. Based on the inspection report, further action would be taken as needed.
Marion Biotech is a licenced producer with a licence from the Drugs Controller of Uttar Pradesh to manufacture Dok1 Max syrup and Tablets for export.
Cough syrup samples were collected from the production site and delivered to the Regional Drugs Testing Laboratory (RDTL) in Chandigarh for testing.
